Yakira Capital Management, Inc.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1584639 Westport, CT

Position in RNA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,693,243

New position

Shares Held

126,645

first reported quarter

Ownership

0.740%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Yakira Capital Management, Inc. holds $5,821,663 across 5 Biotechnology names. RNA ranks #2 (29.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	24,000	$2,755,680
2	RNA	Atrium Therapeutics, Inc. This page	126,645	$1,693,243
3	CNTA	Centessa Pharmaceuticals plc	24,000	$953,280
4	APLS	Apellis Pharmaceuticals, Inc.	6,000	$241,380
5	KZR	Kezar Life Sciences, Inc.	24,000	$178,080

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,693,243	126,645	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.